PMGC Holdings Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
4.960
-0.020 (-0.40%)
At close: Dec 5, 2025, 4:00 PM EST
5.01
+0.05 (1.01%)
After-hours: Dec 5, 2025, 7:42 PM EST
Company Description
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products.
The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
It is also involved in the medical scientific research and development activities, as well as operates investment firms.
The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024.
PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Holdings Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | Nov 21, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Graydon Bensler |
Contact Details
Address: 120 Newport Center Drive, Suite 249 Newport Beach, California 92660 United States | |
| Phone | 866 445 4886 |
| Website | pmgcholdings.com |
Stock Details
| Ticker Symbol | ELAB |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001840563 |
| CUSIP Number | 73017P300 |
| ISIN Number | US73017P3001 |
| Employer ID | 85-1399981 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 3, 2025 | 424B3 | Prospectus |
| Dec 3, 2025 | 424B3 | Prospectus |
| Dec 1, 2025 | EFFECT | Notice of Effectiveness |
| Dec 1, 2025 | EFFECT | Notice of Effectiveness |
| Nov 26, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 26, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | 8-K | Current Report |
| Oct 30, 2025 | 8-K | Current Report |
| Oct 27, 2025 | DEF 14A | Other definitive proxy statements |